Hubei LanSun Biochemical Pharmaceutical Co., Ltd. is a high-tech enterprise engaged in the research and development, production, and sales of chemical drug formulations and active pharmaceutical ingredients. The company focuses on the research and innovation of new drugs for cardiovascular diseases, Alzheimer's disease, weight loss, and gastrointestinal diseases. The company's main products include pharmaceutical intermediates such as methyl pyruvate/ethyl pyruvate/sodium triacetoxyborohydride. All products are eligible for dangerous goods inspection and independent export trade. The total investment of the company is 150 million yuan, covering a total area of 36000 square meters, including two national GMP raw material workshops (sartan raw material workshop and comprehensive preparation workshop), as well as auxiliary facilities such as office, storage, water supply, power supply, and sewage treatment. After reaching production capacity, the company produces 300 tons of raw materials and pharmaceutical intermediates for the treatment of cardiovascular and digestive diseases annually, with an annual output value of approximately 1.5 billion yuan. Hubei LanSun Biochemical Pharmaceutical Co., Ltd. established an enterprise engineering technology research and development center in 2009, specializing in new product development, process improvement, and quality research. It also established a pharmaceutical intermediate research and development laboratory and a product quality control center. The company has fully passed the ISO9001 quality, IS014001 environmental, and IS045001 occupational health and safety management system certifications. Our company's products are widely favored by domestic and foreign customers, and are exported to countries and regions such as the UK, Japan, South Korea, Malta, Romania, Germany, the United States, and Sweden. The company adheres to technological innovation and has obtained a total of 41 national patent technologies (including 9 national invention patents and 32 utility model patents). At the same time, it has established extensive cooperative relationships with research institutions such as Hubei University of Technology and Hubei Institute of Technology, and has established a municipal level school enterprise joint research and development innovation center. In 2022, it will be recognized as a national high-tech enterprise, and in 2025, it will be recognized as a specialized, refined, unique, and new small and medium-sized enterprise in Hubei Province. The company adheres to the concepts of "quality first, reputation first" and "focusing on healthy and green development", and is committed to the development of the pharmaceutical raw material industry and human health, striving to become a world-class pharmaceutical enterprise.
Annual Production
Floor Area
National Patent
Contact：13995963747
Hotline：（086）0714-6395977
Fax：（086）0714-6395977
Email：info@lansunpharma.com
Address：No. 81 Pengcheng Avenue, Huangjinshan Industrial New Area, Huangshi City, Hubei Province, China
ICP filing number: E ICP preparation number 2025164578-1
Hubei LanSun Biochemical Pharmaceutical Co., Ltd.
13995963747 
info@lansunpharma.com 